Related Experiment Videos
Betamethasone and the rhesus fetus: multisystemic effects
American Journal of Obstetrics and Gynecology
|March 15, 1979
Summary
Betamethasone treatment in pregnant monkeys increased fetal lung volumes, suggesting structural changes. Glucocorticoid exposure also caused other fetal and maternal side effects, requiring risk-benefit analysis.
Area of Science:
- Reproductive medicine
- Developmental biology
- Pharmacology
Background:
- Glucocorticoids are used to promote fetal lung maturation.
- The effects of antenatal betamethasone on fetal development require further investigation.
Purpose of the Study:
- To investigate the effects of betamethasone on fetal pulmonary and systemic development in a primate model.
- To assess potential side effects of antenatal glucocorticoid administration.
Main Methods:
- Pregnant rhesus monkeys received betamethasone dosages comparable to human clinical studies.
- Fetal pulmonary, organ, and maternal weights were analyzed.
- Lung volumes were measured using saline inflation.
Main Results:
- Betamethasone administration led to increased fetal lung volumes, indicative of structural alterations.
- Reduced fetal head circumference, thymus, adrenal, and placental weights were observed.
- Increased fetal liver weight and decreased maternal weight were also noted.
Conclusions:
- Antenatal betamethasone may cause significant fetal structural lung changes and other systemic side effects.
- The risk-benefit profile of betamethasone in pregnancy warrants further research.